VGR vs. TTOO

Last updated Apr 2, 2026

Compare and contrast key facts about Vector Group Ltd. (VGR) and T2 Biosystems, Inc. (TTOO).

Performance

VGR vs. TTOO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Vector Group Ltd. (VGR) and T2 Biosystems, Inc. (TTOO). The values are adjusted to include any dividend payments, if applicable.

VGR vs. TTOO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
VGR Vector Group Ltd.	0.00%	0.00%	39.63%	1.92%	11.51%	127.30%	-6.91%	66.05%	-49.30%	11.23%
TTOO T2 Biosystems, Inc.	-96.00%	-98.81%	-93.31%	-95.58%	-94.50%	-58.37%	5.98%	-61.13%	-26.94%	-21.67%

Fundamentals

Total Revenue (TTM) VGR : $1.42B TTOO : $7.68M
Gross Profit (TTM) VGR : $474.37M TTOO : -$5.97M
EBITDA (TTM) VGR : $364.11M TTOO : -$39.51M

Returns By Period

VGR

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

TTOO

• 1D: -33.33%
• 1M: -90.91%
• YTD: -96.00%
• 6M: -98.40%
• 1Y: -99.82%
• 3Y*: -98.37%
• 5Y*: -96.97%
• 10Y*: -85.50%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

VGR vs. TTOO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TTOO

TTOO Risk / Return Rank: 51
TTOO Sharpe Ratio Rank: 39
TTOO Sortino Ratio Rank: 100
TTOO Omega Ratio Rank: 100
TTOO Calmar Ratio Rank: 1
TTOO Martin Ratio Rank: 16

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

VGR vs. TTOO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Vector Group Ltd. (VGR) and T2 Biosystems, Inc. (TTOO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	VGR	TTOO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.02	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.05	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.06	—
Sharpe Ratio (All Time) Calculated using the full available price history	—	-0.06	—

Correlation

The correlation between VGR and TTOO is 0.11, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

VGR vs. TTOO - Dividend Comparison

Neither VGR nor TTOO has paid dividends to shareholders.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
VGR Vector Group Ltd.	0.00%	0.00%	4.00%	7.09%	6.75%	57.77%	6.87%	11.66%	16.05%	6.98%	6.87%	6.62%
TTOO T2 Biosystems, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Drawdowns

Drawdown Indicators

	VGR	TTOO	Difference
Max Drawdown Largest peak-to-trough decline	—	-100.00%	—
Max Drawdown (1Y) Largest decline over 1 year	—	-99.94%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-100.00%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-100.00%	—
Current Drawdown Current decline from peak	—	-100.00%	—
Average Drawdown Average peak-to-trough decline	—	-83.42%	—
Ulcer Index Depth and duration of drawdowns from previous peaks	—	79.92%	—

Volatility

Volatility by Period

	VGR	TTOO	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	604.27%	—
Volatility (6M) Calculated over the trailing 6-month period	—	1,059.16%	—
Volatility (1Y) Calculated over the trailing 1-year period	—	4,239.57%	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	—	1,919.28%	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	—	1,359.36%	—

Financials